Topamax is an anti-convulsant drug manufactured by Ortho-McNeil Neurologics and Noramco, Inc., divisions of Johnson & Johnson. In 1996 it was approved for the treatment of epilepsy and in 2004 it was approved to prevent migraines.
FDA Warning: Risk of oral clefts in children born to mothers taking Topamax (topiramate)
On March 4, 2011, the U.S. Food and Drug Administration informed the public of new data that shows that there is an increased risk for the development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with topiramate (Topamax and generic products) during pregnancy.
Due to the new data that shows an increased risk for oral clefts, the FDA has placed topiramate in Pregnancy Category D. Pregnancy Category D means there is positive evidence of human fetal risk based on human data.
Lawyers are currently investigating defective product claims for Topomax, Topiramate and Topiragen.
If your child developed a cleft lip or cleft palate as a result of the use of Topamax, Topiramate or Topiragen during pregnancy, your child may be entitled to compensation. Contact the Hayes Law Firm today for your free consultation. Please use our free lawyer consultation service or call 1-800-603-6833 to determine whether you have a claim. All consultations are free of charge and will be answered as soon as possible. We are here to help find the best Topomax Lawyers for you.